证券代码：301665 证券简称：泰禾股份 公告编号：2025-025 为开拓海外市场，满足公司未来全球业务发展需要，积极响应国家"一带一 路"政策，南通泰禾化工股份有限公司（以下简称"公司"）于2025年5月19日召 开第三届董事会第十八次会议、第三届监事会第十二次会议，分别审议通过了 《关于对外投资建设农药及功能化学品项目的议案》，同意公司以自有及自筹 资金不超过1.5亿美元（按照1美元兑换人民币7.2150元汇率折算约为10.8225亿 元）在埃及建设农药及功能化学品项目。 根据《深圳证券交易所创业板股票上市规则》《公司章程》等相关规定，本 次投资事项在董事会的审批权限范围内，无需提交公司股东会审议批准，同时 提请董事会授权董事长或其指定人员具体负责办理此项投资的所有后续事项， 包括但不限于决定投资项目的具体实施方式、实施主体、签署相关协议、办理 有关投资备案或审批手续等。 本次对外投资不构成关联交易，亦不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。 二、投资标的的基本情况 南通泰禾化工股份有限公司 关于对外投资建设农药及功能化学品项目的公告 本公司及董事会全体成员保证信息披露内容的真实、 ...

证券代码：301665 证券简称：泰禾股份 公告编号：2025-024 南通泰禾化工股份有限公司 第三届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 南通泰禾化工股份有限公司（以下简称"公司"）第三届监事会第十二次会议 通知已于 2025 年 5 月 13 日通过电子邮件方式送达。会议于 2025 年 5 月 19 日 以现场结合通讯的表决方式在公司会议室召开。本次会议应出席监事 3 名，实际 出席监事 3 名（其中通讯出席 1 人）。会议由监事会主席李正先先生召集并主持。 本次会议的召开符合《中华人民共和国公司法》等法律、法规、规范性文件和《公 司章程》的有关规定，会议合法、有效。 二、监事会会议审议情况 全体监事经过认真审议和表决，形成如下决议： 三、备查文件 第三届监事会第十二次会议决议。 特此公告。 南通泰禾化工股份有限公司 监事会 2025 年 5 月 19 日 1、审议通过《关于对外投资建设农药及功能化学品项目的议案》 经审核，监事会认为：在埃及建设农药及功能化学品项目，公司可以更好地 整合国内 ...

Group 1: Financial Performance - In 2024, the company achieved total revenue of 4.236 billion yuan, a year-on-year increase of 9.51% [2] - The net profit attributable to shareholders was 266 million yuan, a decrease of 23.24% year-on-year; the non-recurring net profit was 258 million yuan, down 25.22% [2] - In Q1 2025, the company reported revenue of 1.033 billion yuan, an 18.50% year-on-year growth; net profit attributable to shareholders was 78.53 million yuan, up 50.93% [2] Group 2: International Business - Over 70% of the company's products are sold internationally; in 2024, overseas revenue reached 3.252 billion yuan, a 10.41% increase, accounting for 76.78% of total revenue [2] Group 3: Core Product Performance - The pesticide segment generated 3.602 billion yuan in revenue in 2024, an 11.40% increase; fungicide revenue was 1.465 billion yuan, up 23.39%, while herbicide revenue reached 1.929 billion yuan, a 2.64% increase [3] - The production and sales volume of pesticides increased by 6.27% and 4.37% respectively, with a production-sales rate of 99.04% and capacity utilization of 94.01% [3] Group 4: Product Development and Market Strategy - The company is focusing on the development of key products such as: - **Bacillus subtilis**: Stable global demand with adjusted sales strategies [3] - **Prothioconazole**: Enhanced market presence through improved production efficiency and cost control [3] - **2,4-D**: Maintained profitability despite market price fluctuations through strategic supplier partnerships [3] - The company is also expanding its portfolio with new products like: - **Prothioconazole**: Expected significant domestic market growth in 2025 [4] - **Oxathiapiprolin**: Aiming to increase market share with improved product recognition [4] Group 5: Future Plans and Risk Management - The company has not established clear merger and acquisition plans or identified potential targets, but will consider these based on strategic development and market conditions [5] - Emphasis on green development and environmental sustainability through energy-saving measures and technological advancements [4]

深交所公开信息显示，当日该股因日换手率达48.07%上榜，机构专用席位净卖出530.09万元。 （文章来源：证券时报网） 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交8580.60万元，其中，买入成交额为 3374.57万元，卖出成交额为5206.03万元，合计净卖出1831.46万元。 MACD金叉信号形成，这些股涨势不错！ 具体来看，今日上榜的营业部中，共有1家机构专用席位现身，即卖四，买入金额30.35万元，卖出金额 560.45万元，合计净卖出530.09万元。 近半年该股累计上榜龙虎榜5次，上榜次日股价平均跌4.71%，上榜后5日平均跌10.90%。 资金流向方面，今日该股主力资金净流出699.46万元，其中，特大单净流出2150.66万元，大单资金净流 入1451.20万元。近5日主力资金净流入2469.63万元。（数据宝） 泰禾股份5月19日交易公开信息 泰禾股份今日上涨9.68%，全天换手率48.07%，成交额5.64亿元，振幅8.17%。龙虎榜数据显示，机构净 卖出530.09万元，营业部席位合计净卖出1301.37万元。 | 买/卖 | 会员营业部名称 | 买入金额（万元） | ...

Market Overview - As of May 16, the Shanghai Composite Index closed at 3367.46 points, down 13.36 points, a decrease of 0.40% [1] - The Shenzhen Component Index closed at 10179.60 points, down 6.85 points, a decrease of 0.07% [1] - The ChiNext Index closed at 2039.45 points, down 3.80 points, a decrease of 0.19% [1] Stock Performance - A total of 113 A-shares had a turnover rate exceeding 20% on this day, indicating significant trading activity [1] - Notable stocks with high turnover rates included: - C Zairun (301636) with a turnover rate of 79.01% and a price increase of 99.52% [1] - C Hanbang (688755) with a turnover rate of 75.65% and a price increase of 102.46% [1] - Ningbo Yuanyang (601022) with a turnover rate of 67.73% and a price increase of 9.98% [1] - Tian Gong Co. (920068) with a turnover rate of 53.83% and a price decrease of 7.78% [1] - Bawei Co. (837023) with a turnover rate of 50.87% and a price decrease of 12.12% [1] Additional Notable Stocks - Other stocks with significant turnover rates included: - Hongqiang Co. (002809) at 49.79% with a price increase of 9.99% [1] - Huafang Co. (600448) at 49.78% with a price decrease of 2.10% [1] - Huaguang Yuanhai (872351) at 46.17% with a price decrease of 11.43% [1] - Jinjiang Shipping (601083) at 41.68% with a price decrease of 8.89% [1] - Zhongzhou Special Materials (300963) at 41.61% with a price increase of 20.00% [1]

Core Insights - The article discusses the increasing demand for the fungicide Bacillus thuringiensis (also known as 2,4,5,6-tetrachloro-1,3-benzodioxole), driven by factors such as the outbreak of soybean rust in Brazil, the growing need for global disease resistance management, and the expansion of crop planting areas in emerging markets like China, India, and Southeast Asia [1][8][10]. Industry Overview - Bacillus thuringiensis is a broad-spectrum protective fungicide with advantages such as high efficiency, low toxicity, broad-spectrum activity, low residue, and long efficacy period [1][8]. - The global demand for Bacillus thuringiensis has increased from 20,000 tons in 2012 to over 60,000 tons in 2024, with projections to reach 72,000 tons by 2025 [1][8]. - The production supply of Bacillus thuringiensis is tightening due to strict environmental policies and limited new production capacity, leading to a continuous increase in market prices [8][10]. Application Demand - Bacillus thuringiensis is widely used in agriculture and forestry for the prevention of fungal diseases, particularly in vegetables and fruits, and is also utilized in non-agricultural areas such as golf courses and ornamental plants [6][8]. - The application demand breakdown shows that 30.45% is in vegetable cultivation, 27.36% in peanuts and grains, 29.36% in fruit cultivation, and 6.22% in other non-agricultural areas [6]. Market Dynamics - The market for Bacillus thuringiensis is highly concentrated, with major production capacities located in China, where leading companies include Zhejiang Limin Holdings, Taihe Co., and Jiangyin Sulin Chemical [14][21]. - The competitive landscape is characterized by a "three-legged" structure dominated by Limin, Sulin, and Jiangsu New River, with the top two companies holding over 80% of the market share [14][21]. Future Trends - The industry is expected to see continued consolidation, with leading companies enhancing their market position through economies of scale and technological barriers [21][22]. - Emerging markets, particularly in Southeast Asia and Brazil, are driving demand growth, prompting domestic companies to accelerate global expansion and establish partnerships with multinational agrochemical firms [22][23]. - The industry is shifting towards green transformation and high-end formulation research, with a focus on developing low-toxicity and low-residue products to meet stricter environmental standards [23].

Core Insights - The report highlights the annual compensation of chairpersons from listed companies in Jiangsu for 2024, showcasing the financial performance and management talent in the region [1][3]. Compensation Rankings - WuXi AppTec's chairman, Li Ge, leads the list with a total compensation of 41.8 million yuan, followed by Taihe Group's Tian Xiaohong with 10.5193 million yuan, marking the only two chairpersons in Jiangsu to exceed 10 million yuan [3]. - A total of 11 chairpersons earn over 5 million yuan, with the pharmaceutical and hardware sectors dominating the high compensation landscape, indicating a strong demand for high-level management talent in high-tech industries [3]. - The semiconductor industry also shows significant compensation levels, with chairpersons from companies like Saiteng Co., Tongfu Microelectronics, and Zhaosheng Microelectronics earning between 3 million and 6 million yuan, reflecting ongoing investments in Jiangsu's chip industry [3]. Gender and Education Disparities - Among the top 100 compensated chairpersons, only one female, Mo Ruoli from Xiangsheng Medical, appears, highlighting the ongoing gender disparity in corporate leadership roles [3]. - There is a strong correlation between educational background and compensation, with many top earners holding doctoral degrees, such as Li Ge (WuXi AppTec) and XIAOLIN ZHANG (Dizhe Pharmaceutical-U) [3]. Age Distribution - Over 50% of the chairpersons are aged between 50 and 60, with those born in the 1970s becoming the main management force. The youngest chairpersons are from Kangli Elevator, Baoli International, and Jujie Microfiber, all aged 32 [3]. Performance and Compensation Concerns - Despite the high compensation figures, there are concerns regarding the alignment of pay with company performance, particularly for ST companies like ST Huifeng and ST Yigou, where the chairpersons' salaries do not correspond with the companies' financial struggles [4].

Group 1: Company Performance and Strategy - The company aims to continuously improve operational efficiency and profitability to enhance investment value and shareholder returns [2] - Over 70% of the company's products are exported, with a low proportion sold to the U.S. market [4] - The company is actively seeking business opportunities in Brazil, a key market for agricultural protection [3] Group 2: Product Development and Market Expansion - The company is working on launching the new pesticide, Cyhalofop-butyl, which requires domestic registration [3] - Plans to diversify into low-carbon chemical products and fluorinated new materials are underway [3] - The company is monitoring trade policy changes to adapt its strategies and maintain market competitiveness [4] Group 3: Financial Concerns and Market Reactions - The company acknowledges that stock price fluctuations are influenced by macroeconomic conditions and market trends [5] - As of the end of 2024, the company has unsold resources amounting to 120 billion yuan, with a high debt ratio of 85% [6] - The company emphasizes that it does not plan to sell core assets or equity as part of its debt restructuring efforts [6]

Core Insights - The company reported a revenue of 4.236 billion yuan for 2024, marking a year-on-year increase of 9.51%, with a net profit attributable to shareholders of 266 million yuan and basic earnings per share of 0.66 yuan [1] - In the first quarter of 2025, the company achieved a revenue of 1.033 billion yuan, reflecting an 18.50% year-on-year growth, with a net profit of 78.53 million yuan, up 50.94%, and a basic earnings per share of 0.19 yuan [1] Group 1 - The company primarily operates in the agricultural chemicals sector, focusing on the research, production, and sales of pesticides and functional chemicals, including fungicides and herbicides [3] - The company has established itself as a leading manufacturing enterprise with core technologies and products, leveraging its own technology and extensive manufacturing management experience [3] Group 2 - The company exports over 70% of its products globally, with a relatively low percentage directed towards the U.S. market, and is implementing a diversified supply chain strategy to mitigate the impact of U.S. tariffs [2] - The company is actively pursuing the registration of new pesticides, including the upcoming launch of cyhalofop-butyl, and is focused on green upgrades in traditional chemical manufacturing [2] - Brazil is identified as a key market for the company, which is seeking to expand its business opportunities in this significant agricultural market [2]

证券代码：301665 证券简称：泰禾股份 公告编号：2025-022 南通泰禾化工股份有限公司 南通泰禾化工股份有限公司（以下简称"公司"）的《2024 年年度报告》 《2024 年年度报告摘要》及《2025 年一季度报告》已于 2025 年 4 月 28 日在巨 潮资讯网（www.cninfo.com.cn）披露。 为使投资者进一步了解公司的财务状况、经营情况及公司发展规划，公司 将于 2025 年 5 月 12 日（星期一）以网络远程方式举行 2024 年度暨 2025 年第 一季度业绩说明会。现将有关事项公告如下： 一、会议时间 2025 年 5 月 12 日（星期一）15:00-17:00 二、会议方式 本次业绩说明会将采用 网 络 远 程 方 式， 投 资 者 可 登 录 "全景 路 演 " （ https://ir.p5w.net/）参与本次业绩说明会。 三、参加方式 为充分尊重投资者，提升交流的针对性，现就本次说明会提前向投资者公 开征集问题，广泛听取投资者的意见和建议。投资者可于 2025 年 5 月 12 日 （星期一）15:00 前访问 https://ir.p5w.net/zj/，或扫 ...